244 related articles for article (PubMed ID: 35064857)
1. Novel insights on GM1 and Parkinson's disease: A critical review.
Fazzari M; Di Biase E; Lunghi G; Mauri L; Chiricozzi E; Sonnino S
Glycoconj J; 2022 Feb; 39(1):27-38. PubMed ID: 35064857
[TBL] [Abstract][Full Text] [Related]
2. Alpha-Synuclein and GM1 Ganglioside Co-Localize in Neuronal Cytosol Leading to Inverse Interaction-Relevance to Parkinson's Disease.
Kumar R; Chowdhury S; Ledeen R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542297
[TBL] [Abstract][Full Text] [Related]
3. The relationship between depletion of brain GM1 ganglioside and Parkinson's disease.
Sonnino S
FEBS Open Bio; 2023 Sep; 13(9):1548-1557. PubMed ID: 36638010
[TBL] [Abstract][Full Text] [Related]
4. Intraventricular Sialidase Administration Enhances GM1 Ganglioside Expression and Is Partially Neuroprotective in a Mouse Model of Parkinson's Disease.
Schneider JS; Seyfried TN; Choi HS; Kidd SK
PLoS One; 2015; 10(12):e0143351. PubMed ID: 26629687
[TBL] [Abstract][Full Text] [Related]
5. The Key Role of GM1 Ganglioside in Parkinson's Disease.
Chowdhury S; Ledeen R
Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204675
[TBL] [Abstract][Full Text] [Related]
6. GDNF signaling implemented by GM1 ganglioside; failure in Parkinson's disease and GM1-deficient murine model.
Hadaczek P; Wu G; Sharma N; Ciesielska A; Bankiewicz K; Davidow AL; Lu ZH; Forsayeth J; Ledeen RW
Exp Neurol; 2015 Jan; 263():177-89. PubMed ID: 25448159
[TBL] [Abstract][Full Text] [Related]
7. Systemic deficiency of GM1 ganglioside in Parkinson's disease tissues and its relation to the disease etiology.
Ledeen R; Chowdhury S; Lu ZH; Chakraborty M; Wu G
Glycoconj J; 2022 Feb; 39(1):75-82. PubMed ID: 34973149
[TBL] [Abstract][Full Text] [Related]
8. A critical role for GM1 ganglioside in the pathophysiology and potential treatment of Parkinson's disease.
Schneider JS
Glycoconj J; 2022 Feb; 39(1):13-26. PubMed ID: 34037912
[TBL] [Abstract][Full Text] [Related]
9. GM1 oligosaccharide efficacy against α-synuclein aggregation and toxicity in vitro.
Fazzari M; Di Biase E; Zaccagnini L; Henriques A; Callizot N; Ciampa MG; Mauri L; Carsana EV; Loberto N; Aureli M; Mari L; Civera M; Vasile F; Sonnino S; Bartels T; Chiricozzi E; Lunghi G
Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Sep; 1868(9):159350. PubMed ID: 37330108
[TBL] [Abstract][Full Text] [Related]
10. Turning the spotlight on the oligosaccharide chain of GM1 ganglioside.
Chiricozzi E; Di Biase E; Lunghi G; Fazzari M; Loberto N; Aureli M; Mauri L; Sonnino S
Glycoconj J; 2021 Feb; 38(1):101-117. PubMed ID: 33620588
[TBL] [Abstract][Full Text] [Related]
11. GM1 Ganglioside Is A Key Factor in Maintaining the Mammalian Neuronal Functions Avoiding Neurodegeneration.
Chiricozzi E; Lunghi G; Di Biase E; Fazzari M; Sonnino S; Mauri L
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013258
[TBL] [Abstract][Full Text] [Related]
12. GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson's Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson's Disease-Relevant Pathogenic Mechanisms.
Schneider JS
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298133
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans.
Wu G; Lu ZH; Kulkarni N; Ledeen RW
J Neurosci Res; 2012 Oct; 90(10):1997-2008. PubMed ID: 22714832
[TBL] [Abstract][Full Text] [Related]
14. The oligosaccharide portion of ganglioside GM1 regulates mitochondrial function in neuroblastoma cells.
Fazzari M; Audano M; Lunghi G; Di Biase E; Loberto N; Mauri L; Mitro N; Sonnino S; Chiricozzi E
Glycoconj J; 2020 Jun; 37(3):293-306. PubMed ID: 32266604
[TBL] [Abstract][Full Text] [Related]
15. GM1 ganglioside modifies microglial and neuroinflammatory responses to α-synuclein in the rat AAV-A53T α-synuclein model of Parkinson's disease.
Schneider JS; Singh G; Williams CK; Singh V
Mol Cell Neurosci; 2022 May; 120():103729. PubMed ID: 35447351
[TBL] [Abstract][Full Text] [Related]
16. Gangliosides in the differentiation process of primary neurons: the specific role of GM1-oligosaccharide.
Di Biase E; Lunghi G; Fazzari M; Maggioni M; Pomè DY; Valsecchi M; Samarani M; Fato P; Ciampa MG; Prioni S; Mauri L; Sonnino S; Chiricozzi E
Glycoconj J; 2020 Jun; 37(3):329-343. PubMed ID: 32198666
[TBL] [Abstract][Full Text] [Related]
17. Interactions of GM1 ganglioside with crude rat brain neuronal membranes.
Toffano G; Benvegnù D; Bonetti AC; Facci L; Leon A; Orlando P; Ghidoni R; Tettamanti G
J Neurochem; 1980 Oct; 35(4):861-6. PubMed ID: 7452294
[TBL] [Abstract][Full Text] [Related]
18. Ganglioside GM1 and the Central Nervous System.
Guo Z
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298512
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease recovery by GM1 oligosaccharide treatment in the B4galnt1
Chiricozzi E; Mauri L; Lunghi G; Di Biase E; Fazzari M; Maggioni M; Valsecchi M; Prioni S; Loberto N; Pomè DY; Ciampa MG; Fato P; Verlengia G; Cattaneo S; Assini R; Wu G; Alselehdar S; Ledeen RW; Sonnino S
Sci Rep; 2019 Dec; 9(1):19330. PubMed ID: 31852959
[TBL] [Abstract][Full Text] [Related]
20. Effect of GM1 concentration change on plasma membrane: molecular dynamics simulation and analysis.
Lyu Y; Chen S; Zhao Y; Yuan H; Zhang C; Zhang C; Meng Q
Phys Chem Chem Phys; 2024 Apr; 26(16):12552-12563. PubMed ID: 38595108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
